trending Market Intelligence /marketintelligence/en/news-insights/trending/5tnO35CWIqKvXKbagY_rrQ2 content esgSubNav
In This List

US FDA authorizes expanded use of Abbott's Zika virus test

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


US FDA authorizes expanded use of Abbott's Zika virus test

The U.S. FDA expanded its emergency use authorization of Abbott Laboratories' RealTime Zika test for the detection of the virus in whole blood samples.

Previously, the test was authorized for use with serum, plasma and urine samples.